timothy sykes logo
PMI Stock Slides As Losses Mount And Liquidity Tightens Thumbnail

PMI Stock Slides As Losses Mount And Liquidity Tightens

BRYCE TUOHEYUPDATED AUG. 21, 2026, 8:33 AM ET
Reviewed by Tim Sykesand Fact-checked by Matt Monaco

Picard Medical Inc. rallies as pivotal positive clinical news fuels bullish sentiment; stocks have been trading up by 17.49 percent.

Key Takeaways

  • Recent trading shows PMI fading from early August highs above $5, with the stock now fighting to hold the low-$3s.
  • The latest report shows Picard Medical Inc. posting about $2.95M in quarterly revenue but more than $5.6M in net losses, a deep red profile.
  • PMI’s margins are sharply negative, with thin gross profit and heavy operating costs, highlighting a classic high-risk, early-stage balance.
  • Liquidity looks tight for Picard Medical Inc., with a current ratio near 0.8 and minimal cash on hand, forcing traders to respect dilution and financing risk.
  • Active traders are watching PMI’s intraday volatility and prior support near $3 as key short-term trading lines in the sand.

Candlestick Chart

Live Update At 08:33:27 EDT: On Friday, August 21, 2026 Picard Medical Inc. stock [NYSE American: PMI] is trending up by 17.49%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PMI is trading like a small-cap name under pressure. On the daily chart, Picard Medical Inc. has retreated from an early-August push above $5 to recent closes around $3.03–$3.29. That’s a sharp drawdown, and it tells traders momentum has shifted from aggressive buyers to cautious, short-term players managing risk tightly.

Financially, PMI looks very early stage and very unprofitable. The latest quarterly numbers show about $2.95M in revenue and only $616,000 in gross profit, implying a thin 7.8% gross margin. Then the wheels come off. Operating income is roughly -$4.63M, and net income is about -$5.66M. That’s a heavy burn for a company this small.

Picard Medical Inc. also shows a current ratio under 1 and cash of only about $38,000 against current liabilities over $7.4M. Working capital is barely positive. For traders, that screams “funding overhang.” PMI needs outside capital to keep moving, which often means potential offerings and volatility around those events.

Why Traders Are Watching PMI Price Action

PMI may not be a household name, but the chart is exactly what active traders hunt: fast moves, clear levels, and a story of survival on the financial side. Picard Medical Inc. exploded from the low-$4s to an intraday high above $5.40 in early August, then rolled over hard. Since then, closes have marched lower from $5.13 to around $3.03, with multiple failed bounces near $3.60–$3.70. That kind of stair-step fade often signals bag-holders and short-term traders selling every pop.

On the most recent intraday action, PMI printed a wild premarket range. In just a few five-minute candles, Picard Medical Inc. ripped from about $3.10 to as high as $5.50, then dumped back toward the low-$3s. That’s textbook liquidity-trap behavior: thin order books, aggressive day traders, and algos exploiting every overextension. For disciplined traders, this offers opportunity, but only with strict risk rules and hard stops.

Under the hood, PMI’s fundamentals back up the story of a speculative, binary-style name. Picard Medical Inc. is running with deeply negative profit margins, negative free cash flow of about -$1.35M for the quarter, and retained earnings near -$89.85M. Return on assets is around -149%, which tells traders the business is burning cash much faster than it’s generating value.

Yet PMI still posts nearly $4.94M in trailing revenue and holds about $9.17M in total assets, mostly inventory. That’s why active traders keep PMI on watch: it’s not a “zero revenue shell,” but it is high-risk, high-volatility, and very sensitive to any shift in sentiment or capital flow.

Conclusion

For short-term players, PMI sits at a critical spot on the chart. Picard Medical Inc. has already given back its early-August surge, and price is now hovering just above recent lows around $3. If PMI loses that $3 area with volume, many momentum traders will step aside or even look for short setups where borrow is available. If Picard Medical Inc. holds and starts reclaiming the mid-$3s, the stock may offer one more squeeze as shorts lock in gains and late sellers chase back in.

Fundamentally, Picard Medical Inc. remains a story of tight liquidity and heavy losses. PMI’s low cash balance, negative margins, and modest revenue base mean any aggressive expansion or delay in funding can hit the stock hard. That’s exactly the type of situation where traders must avoid marrying the stock and instead focus on patterns, volume, and clear risk levels.

As Tim Sykes likes to remind traders, “The market doesn’t care about your opinion, only your discipline.” As millionaire penny stock trader and teacher Tim Sykes, says, “Embrace the journey, the ups and downs; each mistake is a lesson to improve your strategy.”. PMI is a real-time example. Picard Medical Inc. offers volatility, but also real risk. For educational and research-focused traders, the lesson is simple: study the chart, understand the financial burn, plan entries and exits in advance, and always remember that capital preservation beats chasing every hot move.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:


How much has this post helped you?



Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”